Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Petschner

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|April 10, 2019
[Anxiety and depression - the role of blood-brain barrier integrity]Zsofia Gal, Robin J Huse, Xenia Gonda, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|April 10, 2019
Transcriptomic changes following chronic administration of selective serotonin reuptake inhibitors: a review of animal studiesSahel Kumar, Zsofia Gal, Xenia Gonda, et al.
BMC Genomics|January 1, 2014
Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti ratsPeter Petschner, Viola Tamasi, Csaba Adori, et al.
BMC Genomics|August 4, 2018
Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti ratsPeter Petschner, Viola Tamasi, Csaba Adori, et al.
Life (Basel, Switzerland)|May 28, 2022
Chronic Exposure to the Food Additive tBHQ Modulates Expression of Genes Related to SARS-CoV-2 and Influenza VirusesKrisztina Németh, Peter Petschner, Krisztina Pálóczi, et al.
Pharmacology & Therapeutics|September 7, 2018
Genetic variants in major depressive disorder: From pathophysiology to therapyXenia Gonda, Peter Petschner, Nora Eszlari, et al.
Plos One|November 26, 2014
Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processesViola Tamási, Peter Petschner, Csaba Adori, et al.
Brain, Behavior, and Immunity|February 20, 2016
Effects of IL1B single nucleotide polymorphisms on depressive and anxiety symptoms are determined by severity and type of life stressDavid Kovacs, Nora Eszlari, Peter Petschner, et al.
Plos One|December 31, 2021
A replication study separates polymorphisms behind migraine with and without depressionPeter Petschner, Daniel Baksa, Gabor Hullam, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 29, 2016
Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypesDavid Kovacs, Nora Eszlari, Peter Petschner, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|April 10, 2019
[Anxiety and depression - the role of blood-brain barrier integrity]Zsofia Gal, Robin J Huse, Xenia Gonda, et al.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|April 10, 2019
Transcriptomic changes following chronic administration of selective serotonin reuptake inhibitors: a review of animal studiesSahel Kumar, Zsofia Gal, Xenia Gonda, et al.
BMC Genomics|January 1, 2014
Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti ratsPeter Petschner, Viola Tamasi, Csaba Adori, et al.
BMC Genomics|August 4, 2018
Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti ratsPeter Petschner, Viola Tamasi, Csaba Adori, et al.
Life (Basel, Switzerland)|May 28, 2022
Chronic Exposure to the Food Additive tBHQ Modulates Expression of Genes Related to SARS-CoV-2 and Influenza VirusesKrisztina Németh, Peter Petschner, Krisztina Pálóczi, et al.
Pharmacology & Therapeutics|September 7, 2018
Genetic variants in major depressive disorder: From pathophysiology to therapyXenia Gonda, Peter Petschner, Nora Eszlari, et al.
Plos One|November 26, 2014
Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processesViola Tamási, Peter Petschner, Csaba Adori, et al.
Brain, Behavior, and Immunity|February 20, 2016
Effects of IL1B single nucleotide polymorphisms on depressive and anxiety symptoms are determined by severity and type of life stressDavid Kovacs, Nora Eszlari, Peter Petschner, et al.
Plos One|December 31, 2021
A replication study separates polymorphisms behind migraine with and without depressionPeter Petschner, Daniel Baksa, Gabor Hullam, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 29, 2016
Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypesDavid Kovacs, Nora Eszlari, Peter Petschner, et al.
Pageof 4